Ovarian stimulation and egg retrieval in the acutely ill patient: special considerations
- 93 Downloads
Over the past decades, assisted reproductive care has become increasingly safe and more widely applied. Egg retrieval has become an outpatient procedure, with ultrasound guidance, and stimulations have increasingly become less aggressive and safer with more individualization and safer trigger options. With this improvement in care, these treatments are considered low risk and applied more widely, including fertility preservation for elective reasons (so-called social egg freezing). However, it is incumbent upon providers to realize the application of even “simple” treatments, in a high-risk population, may have serious consequences.
As long-term survival rates have improved among patients diagnosed with cancer and life-threatening disease, and with these improved survival rates, post-treatment quality of life has gained increased attention . Among this growing population with life-threatening illness and greater survival expectation are women of reproductive age, and...
- 1.Centers for Disease Control. A national action plan for cancer survivorship: advancing public health strategies. 2004 12/20/2018]; Available from: https://www.cdc.gov/cancer/survivors/pdf/plan.pdf.
- 2.Surveillance, epidemiology, and end results program. Cancer statistics and review 1975–2015. [cited 2018; Available from: http://www.seer.cancer.gov.
- 4.Ethics Committee of the American Society for Reproductive Medicine. Electronic address, A.a.o., Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion. Fertil Steril, 2018. 110(3): p. 380–386.Google Scholar
- 18.Graetz T, N.D. Perioperative strategies to reduce bleeding and minimize transfusions. UpToDate. 2018; Available from: http://www.uptodate.com.
- 23.Brunicardi FC, et al. Schwartz’s principles of surgery. Tenth ed. New York: McGraw-Hill Education; 2014.Google Scholar
- 28.Mahajan A, et al. The epidemiology of cancer-associated venous thromboembolism: an update. Semin Thromb Hemost. 2019.Google Scholar
- 34.Practice Committee of the American Society for Reproductive Medicine. Electronic address, A.a.o. and M. Practice Committee of the American Society for reproductive, prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril, 2016. 106(7): p. 1634–1647.Google Scholar
- 36.Namavar Jahromi BM, et al. Ovarian hyperstimulation syndrome: a narrative review of its pathophysiology, risk factors, prevention, classification, and management. Iran J Med Sci. 2018;43(3):248–60.Google Scholar
- 39.Youssef MA, et al. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles. Cochrane Database Syst Rev. (2011, 1):CD008046.Google Scholar
- 40.Anaya Y, Mata DA, Letourneau J, Cakmak H, Cedars MI, Rosen MP. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols (vol 35, pg 297, 2017). J Assist Reprod Genet. 2018;35(2):309–9.Google Scholar